HHS to allow sale of unapproved peptides under review

From The Hill

The Department of Health and Human Services (HHS) will allow compounding pharmacies to manufacture and sell peptides that have not yet been added to the list of approved substances, advancing access to those championed by the “Make America Healthy Again” (MAHA) agenda. The HHS stated in a notice that it would be practicing enforcement discretion…

Source Author
Author: Source Author

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *